Im excited to continue to use it
[DOI] [PubMed] [Google Scholar] 78.Turkovic B., Sikiric P., Seiwerth S., Mise S., Anic T., Petek M
Why Is There So Little Human Research and Clinical Trial Evidence on BPC-157
On the other hand, too high a concentration of the peptide (toxic concentration), in a dose higher than recommended, may be harmful to the body
A clinical study on modified growth hormone releasing factor (CJC-1295) demonstrated sustained increases in GH and IGF-1 levels following repeated dosing with a favorable safety profile, supporting the use of consistent dosing over multi-week protocols
Given the fact that vitamin B12 levels were increased insignificantly among all routes, the preference of the administrated route should be referenced to the advantages and disadvantages of each route as well as the patient situation, which will be decided according to the physicians opinion